The Ashburn, Va.-based specialty pharmaceutical company, which develops therapeutic products for rare and orphan diseases, said the offering would put up for sale 24.8 million ordinary shares represented by 5 million American Depositary Shares at a purchase price of $1.00 per ADS, as well as pre-funded warrants to purchase 10.3 million ordinary shares represented by 2.1 million ADSs at a pre-funded warrant price of $0.9999 per ADS.
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.